Skip to content

    LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) stock price & financials

    View LFCR earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance39.7% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $37.88M
    $24.70M
    $32.56M
    $35.15M
    $36.44M
    -3.8%
    $31.11M
    +25.9%
    $23.19M
    -28.8%
    $34.17M
    -2.8%
    Stable
    Operating Profit
    $2.15M
    -$11.58M
    -$1.96M
    -$9.03M
    $5.33M
    +148.0%
    -$3.07M
    +73.5%
    -$4.67M
    -138.5%
    $2.57M
    Weakening
    Net Profit
    -$7.08M
    -$16.23M
    -$6.57M
    -$14.77M
    -$1.15M
    +83.8%
    -$9.99M
    +38.4%
    -$14.98M
    -128.0%
    -$6.16M
    +58.3%
    Weakening
    EPS
    $-0.53
    $-0.25
    $-0.42
    $-0.06
    $-0.29
    +45.3%
    $-0.43
    -72.0%
    $-0.19
    +54.8%
    Strengthening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    -$7.14M
    -$16.25M
    -$6.53M
    -$14.78M
    -$1.11M
    +84.4%
    -$9.66M
    +40.6%
    -$14.94M
    -128.8%
    -$6.13M
    +58.5%
    Weakening
    MarginsOPM
    5.7%
    -46.9%
    -6.0%
    -25.7%
    14.6%
    +157.8%
    -9.9%
    +79.0%
    -20.1%
    -234.6%
    7.5%
    Weakening
    Tax
    0.8%
    0.1%
    -0.7%
    0.1%
    -3.0%
    -470.0%
    -3.5%
    -2400.0%
    -0.3%
    +56.1%
    -0.4%
    -860.0%
    Weakening
    ReturnsROIC
    2.9%
    6.6%
    2.7%
    6.0%
    0.5%
    -83.8%
    4.1%
    -38.4%
    6.1%
    +128.0%
    2.5%
    -58.3%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$2.90M$1.08M$360.0K$763.0K$991.0K$19.09M$8.46M$8.27M$17.24M
    Short-Term Investments
    Total Current Assets$97.06M$133.04M$157.11M$145.30M$116.67M$93.88M$81.03M$85.68M$83.69M
    Net PP&E$159.62M$200.03M$217.66M$120.67M$124.22M$138.67M$151.61M$129.01M$123.71M
    Goodwill$54.51M$76.74M$33.92M$13.88M$13.88M$13.88M$13.88M$13.88M$13.88M
    Intangibles$21.84M$15.32M$12.78M$8.04M$1.07M$4.20M$4.20M$4.20M
    Total Assets$404.70M$519.09M$293.50M$501.88M$274.70M$253.54M$253.96M$239.34M$229.50M
    LiabilitiesTotal Current Liabilities$88.38M$137.09M$164.39M$101.85M$176.58M$39.29M$38.87M$30.18M$21.64M
    Short-Term Debt$4.94M$9.79M$11.55M$0$98.18M$580.0K$943.0K$3.44M$970.0K
    Long-Term Debt$37.36M$87.19M$101.36M$164.90M$0$84.26M$100.82M$130.44M$155.07M
    Long-Term Leases$22.94M$20.30M$9.97M$6.50M$1.73M$1.34M$928.0K
    Total Liabilities$152.14M$248.95M$310.27M$299.94M$186.88M$218.46M$200.06M$191.91M$213.41M
    EquityCommon Stock & APIC$28.0K$29.0K$29.0K$29.0K$30.0K$30.0K$31.0K$37.0K$38.0K
    Retained Earnings$109.30M$109.71M$71.25M$37.74M-$78.97M-$178.54M-$166.52M-$205.24M-$244.34M
    Total Equity$252.56M$270.14M$229.84M$201.95M$87.82M-$4.23M$11.31M$1.34M-$34.09M
    HighlightsNet Cash / (Debt)-$39.40M-$95.90M-$112.56M-$164.14M-$97.19M-$65.75M-$93.30M-$125.61M-$138.80M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$19.78M$16.02M-$17.04M$16.47M-$22.59M-$17.44M$257.0K-$206.0K$9.62M
    Cash from Investing-$35.59M-$96.80M-$23.89M-$12.31M$79.96M-$4.81M-$18.39M-$6.42M-$5.46M
    Cash from Financing$13.29M$79.03M$40.02M-$3.42M-$57.02M$39.70M$7.51M$6.42M-$2.90M
    SummaryCapital Expenditure-$33.59M-$44.73M-$12.21M-$19.26M-$26.23M-$18.39M-$13.41M-$5.46M
    Free Cash Flow-$13.81M-$28.71M-$29.25M-$2.79M-$48.82M-$18.14M-$13.62M$4.16M
    FCF Margin-2.6%-5.1%-18.3%-2.8%-43.9%-14.1%-10.6%3.3%

    Ratios